Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker

Cerebrospinal fluid and positron emission tomography biomarkers accurately predict an underlying Alzheimer's disease (AD) pathology; however, they represent either invasive or expensive diagnostic tools. Therefore, a blood-based biomarker like plasma amyloid beta (Aβ) that could correlate with...

Full description

Saved in:
Bibliographic Details
Main Authors: Toledo, Jon B, Shaw, Leslie M, Trojanowski, John Q
Format: Artigo
Language:Inglês
Published: BioMed Central 2013
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3706955/
https://ncbi.nlm.nih.gov/pubmed/23470128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt162
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items